Atelerix Ltd. specializes in advanced cell preservation technologies, particularly focusing on the encapsulation of cells in a protective matrix. This innovative approach allows for the long-term storage and transport of sensitive biological materials, such as stem cells and other cell types, without compromising their viability. The company employs a unique method that utilizes a biocompatible hydrogel, which provides a stable environment for cells, ensuring they remain functional and ready for use in various applications, including research and therapeutic purposes.

In addition to cell encapsulation, Atelerix is committed to enhancing the efficiency of cell-based therapies. Their technology facilitates the safe and effective delivery of cells, addressing common challenges associated with traditional preservation methods. By optimizing the conditions under which cells are stored and transported, Atelerix aims to improve the overall success rates of cell therapies, making them more accessible and reliable for clinical applications. This focus on innovation positions Atelerix as a key player in the field of regenerative medicine and biotechnology.

United Kingdom

Crafting shelf-stable science inspired by hedgehogs, Atelerix is the answer to the cryopreservation headache. With a gel that's not just cool but doesn't need to be cold, they're setting cells, tissues, and viruses free from the icy grip of traditional storage and shipping methods. Welcome to the future of bioscience, where the storage is easy, and the cells are always fresh.

Institute Of Genetic Medicine Newcastle University, International Centre For Life Central Parkway, Newcastle upon Tyne, England, GB, NE1 3BZ

Atelerix Ltd.

Company Details